CN102861241B - Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction - Google Patents

Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction Download PDF

Info

Publication number
CN102861241B
CN102861241B CN201210364689.7A CN201210364689A CN102861241B CN 102861241 B CN102861241 B CN 102861241B CN 201210364689 A CN201210364689 A CN 201210364689A CN 102861241 B CN102861241 B CN 102861241B
Authority
CN
China
Prior art keywords
chinese medicine
radix
myocardial infarction
traditional chinese
acute myocardial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201210364689.7A
Other languages
Chinese (zh)
Other versions
CN102861241A (en
Inventor
宋燕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210364689.7A priority Critical patent/CN102861241B/en
Publication of CN102861241A publication Critical patent/CN102861241A/en
Application granted granted Critical
Publication of CN102861241B publication Critical patent/CN102861241B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction. The acute myocardial infarction belongs to the range of 'chest obstruction' and 'angina pectoris' of the traditional Chinese medicine. The disease location of the acute myocardial infarction is the heart of a human body, the deficiency is the cause, cold congealing, qi stagnation, blood stasis and phlegm are symptoms, and the nature of the disease is shown as deficient cause with overdo superficial and intermingled deficiency and excess. Accordingly, traditional Chinese medicinal materials such as fruits of camphor trees, roots of divaricate knotweed herbs, roots of kerr treebine, licorice, radix puerariae, astragalus membranaceus, lignum dalbergiae odoriferae, salvia miltiorrhiza, ligusticum chuanxiong, saffron crocus, fructus aurantii, ladybell roots and dendrobium which have effects of clearing heat, eliminating phlegm, promoting blood circulation to remove blood stasis, supplementing qi and nourishing yin are selected and prepared into the soup. As clinical tests on 144 patients in a hospital, total effective rate reaches 97.2%, a perfect curative effect is realized, and the traditional Chinese medicine qi-reinforcing and stasis-removing soup is worthy of being clinically popularized and applied.

Description

A kind of Chinese medicine QI invigorating Huayu Tang for the treatment of acute myocardial infarction
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine QI invigorating Huayu Tang for the treatment of acute myocardial infarction.
Background technology
Acute myocardial infarction is again in acute myocardial infarction, and morbidity is anxious, and change of illness state is fast, easily complicated by arrhythmia, heart failure, cardiogenic shock etc., and case fatality rate, up to 6%~30%, is the clinical common critical illness of emergency treatment.Conventional treatment comprises strict bed rest, oxygen uptake, cardio-pulmonary resuscitation, thrombolytic, arrhythmia etc. clinically.My institute proves through clinical research for many years, utilizes Chinese medicine symptomatic treatment can improve significantly the generation for the treatment of success rate and minimizing complication.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine QI invigorating Huayu Tang for the treatment of acute myocardial infarction.Acute myocardial infarction belongs to motherland's medical science " thoracic obstruction ", " angina pectoris " category.The sick position of primary disease is at the heart, and taking void as this, cold coagulation, the stagnation of QI, blood stasis, expectorant is turbid is mark, and characteristic of disease is the card of deficiency in origin and excess in superficiality, simulataneous insufficiency and excessive.The traditional Chinese medical science treatment on taking removing heat-phlegm, blood circulation promoting and blood stasis dispelling, supplementing QI and nourishing YIN as the rule for the treatment of.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine QI invigorating Huayu Tang of this treatment acute myocardial infarction is made up of the Chinese medicine of following weight portion: Fructus litseae rubescentis 10-15 part, Radix polygoni divaricati 10-15 part, Radix Cissi Kerrii 10-12 part, Radix Glycyrrhizae 5-7 part, Radix Puerariae 13-15 part, Radix Astragali 15-20 part, Lignum Dalbergiae Odoriferae 9-11 part, Radix Salviae Miltiorrhizae 14-16 part, Rhizoma Chuanxiong 11-13 part, Stigma Croci 8-10 part, Fructus Aurantii 9-11 part, Radix Adenophorae 11-13 part, Herba Dendrobii 11-13 part.
Preferably, 13 parts of Fructus litseae rubescentis, 13 parts of Radix polygoni divaricaties, 11 parts of Radix Cissi Kerrii, 6 parts, Radix Glycyrrhizae, 14 parts of Radix Puerariaes, 18 parts of the Radixs Astragali, 10 parts of Lignum Dalbergiae Odoriferaes, 15 parts of Radix Salviae Miltiorrhizaes, 12 parts of Rhizoma Chuanxiongs, 9 parts of Stigma Crocis, 10 parts of Fructus Aurantiis, 12 parts of Radix Adenophoraes, 12 parts of Herba Dendrobiis.
Preparation method is made decoction by above-mentioned Chinese medicine by traditional method.
Fang Zhong: Fructus litseae rubescentis: expelling wind and cold, relieving dyspepsia; Radix polygoni divaricati: the kidney warming of dispeling cold; Radix Cissi Kerrii: heat-clearing and toxic substances removing, eliminating stagnation promoting the circulation of blood; Radix Glycyrrhizae: QI invigorating invigorating middle warmer, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, alleviates pain relieving; Radix Puerariae: expelling pathogenic factors from muscles for reducing heat, treating measles, promoting the production of body fluid to quench thirst; The Radix Astragali: the raw sun of QI invigorating, benefit is consolidating superficial resistance, inducing diuresis to remove edema, holder skin ulcer life; Lignum Dalbergiae Odoriferae: removing stasis to stop bleeding, regulating QI to relieve pain.Radix Salviae Miltiorrhizae: promoting blood flow to regulate menstruation, removing heat from blood eliminating carbuncle, calms the nerves; Rhizoma Chuanxiong: blood-activating and qi-promoting, wind-expelling pain-stopping; Stigma Croci; Blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens; Fructus Aurantii: dispelling the stagnated QI is except painful abdominal mass, transforming phlegm and dispersing accumulations; Radix Adenophorae: nourishing YIN and clearing away lung-heat, the QI invigorating of reducing phlegm; Herba Dendrobii: replenishing YIN and removing heat, reinforcing stomach reg fluid.
Clinical data
The selected 144 routine cases of physical data meet Diagnosis of Acute Myocardial Infarction standard, all, from February, 2002~2008 patient that year accept for medical treatment in emergency department of Jian Wo institute in November ward, are divided at random two groups, treatment group 72 examples, wherein male 43 examples, female's 29 examples; 40~79 years old age, average 63.1 years old; Matched group 72 examples, wherein male 45 examples, female's 27 examples; 41~77 years old age, average 62.5 years old.Two groups of patients' morbidity is to data Epidemiological Analysis processing by statistics such as admission time, severity extent, infarction position, age, sexes, and no significant difference (P > 0.05), illustrates that two groups of data have comparability.
Diagnostic criteria chest pain continues > 30min, and rest and buccal nitroglycerin are not alleviated; At least two the adjacent S-T of leading sections of electrocardiogram are raised; In morbidity 6h; Without thrombolytic contraindication; All be diagnosed as acute myocardial infarction; Tcm syndrome standard: the vexed pain in ambition or causalgia connect and back, accompany vomiting and nausea uncomfortable in chest, bitter taste abundant expectoration, insomnia and dreamful sleep, large dry stool, dimly red tongue, yellow and thin fur or yellow greasy, rolling pulse or sliding number.
Therapeutic Method treatment group is taken Chinese medicine Chinese medicine QI invigorating Huayu Tang of the present invention, every day potion, early, evening point secondary clothes; The oral isosorbide dinitrate tablets sublingual administration of matched group, sorbitrate, aspirin; Two groups of homogeneous Zhou Weiyi courses for the treatment of.
The criterion of criterion of therapeutical effect clinical efficacy is with reference to " new Chinese medicine guideline of clinical investigations " (first volume, version in 1993) curative effect determinate standard of " guideline of clinical investigations of the new Chinese medicine treatment thoracic obstruction (angina pectoris) " drafts: effective: clinical symptom disappearance, it is normal that myocardial zymetology recovers, and ECG ST section recovers normally or only to stay pathologic Q ripple and (or) coronary T wave; Effective: clinical symptoms disappears substantially, electrocardiogram has Q to involve the change that ST-T takes a turn for the better; Invalid: clinical symptoms is not alleviated, electrocardiogram is without improvement, even dead.
Two groups of treatments of therapeutic outcome are added up curative effect after two courses for the treatment of, treatment group 72 effective 50 examples of example (69.4%), and effective 20 examples (27.8%), invalid 2 examples (2.8%), total effective rate reaches 97.2%; Matched group 72 effective 30 examples of example (41.7%), effective 29 examples (40.3%), invalid 13 examples (18.1%), total effective rate reaches 81.9%; Two groups control obvious effective rate, total effective rate has significant difference (P < 0.05).
Detailed description of the invention
Embodiment mono-: take Fructus litseae rubescentis 13g, Radix polygoni divaricati 13g, Radix Cissi Kerrii 11g, Radix Glycyrrhizae 6g, Radix Puerariae 14g, Radix Astragali 18g, Lignum Dalbergiae Odoriferae 10g, Radix Salviae Miltiorrhizae 15g, Rhizoma Chuanxiong 12g, Stigma Croci 9g, Fructus Aurantii 10g, Radix Adenophorae 12g, Herba Dendrobii 12g, make according to a conventional method decoction, every day potion, early, evening point secondary clothes.
Embodiment bis-: take Fructus litseae rubescentis 10g, Radix polygoni divaricati 10g, Radix Cissi Kerrii 10g, Radix Glycyrrhizae 5g, Radix Puerariae 13g, Radix Astragali 15g, Lignum Dalbergiae Odoriferae 9g, Radix Salviae Miltiorrhizae 14g, Rhizoma Chuanxiong 11g, Stigma Croci 8g, Fructus Aurantii 9g, Radix Adenophorae 11g, Herba Dendrobii 11g makes decoction according to a conventional method, every day potion, early, evening point secondary clothes.
Embodiment tri-: take Fructus litseae rubescentis 15g, Radix polygoni divaricati 15g, Radix Cissi Kerrii 12g, Radix Glycyrrhizae 7g, Radix Puerariae 15g, Radix Astragali 20g, Lignum Dalbergiae Odoriferae 11g, Radix Salviae Miltiorrhizae 16g, Rhizoma Chuanxiong 13g, Stigma Croci 10g, Fructus Aurantii 11g, Radix Adenophorae 13g, Herba Dendrobii 13g makes decoction according to a conventional method, every day potion, early, evening point secondary clothes.

Claims (1)

1. treat a Chinese medicine QI invigorating Huayu Tang for acute myocardial infarction, it is characterized in that this Chinese medicine QI invigorating Huayu Tang is made up of the Chinese medicine of following weight portion: Fructus litseae rubescentis 13g, Radix polygoni divaricati 13g, Radix Cissi Kerrii 11g, Radix Glycyrrhizae 6g, Radix Puerariae 14g, Radix Astragali 18g, Lignum Dalbergiae Odoriferae 10g, Radix Salviae Miltiorrhizae 15g, Rhizoma Chuanxiong 12g, Stigma Croci 9g, Fructus Aurantii 10g, Radix Adenophorae 12g, Herba Dendrobii 12g.
CN201210364689.7A 2012-09-18 2012-09-18 Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction Expired - Fee Related CN102861241B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210364689.7A CN102861241B (en) 2012-09-18 2012-09-18 Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210364689.7A CN102861241B (en) 2012-09-18 2012-09-18 Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction

Publications (2)

Publication Number Publication Date
CN102861241A CN102861241A (en) 2013-01-09
CN102861241B true CN102861241B (en) 2014-06-18

Family

ID=47440556

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210364689.7A Expired - Fee Related CN102861241B (en) 2012-09-18 2012-09-18 Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction

Country Status (1)

Country Link
CN (1) CN102861241B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127595A (en) * 2014-07-14 2014-11-05 刘平平 Myocardial infarction treatment medicine and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102784A (en) * 1994-02-28 1995-05-24 虹雨集团公司 Chinese patent medicine for prevention and control of ischemic cardio-cerebral angiopathy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101611874A (en) * 2008-06-26 2009-12-30 赵朋 Health tea for preventing angina pectoris
CN101708313B (en) * 2009-12-18 2011-06-22 张铭连 Pharmaceutical composition for promoting blood circulation and removing obstruction in channels

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1102784A (en) * 1994-02-28 1995-05-24 虹雨集团公司 Chinese patent medicine for prevention and control of ischemic cardio-cerebral angiopathy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127595A (en) * 2014-07-14 2014-11-05 刘平平 Myocardial infarction treatment medicine and preparation method thereof

Also Published As

Publication number Publication date
CN102861241A (en) 2013-01-09

Similar Documents

Publication Publication Date Title
CN102078510B (en) Chinese medicinal composition for treating coronary heart disease
CN102988843B (en) Traditional Chinese medicine Tongfengling used for treating chronic gouty arthritis
CN105012735B (en) One kind fills blood anticancer traditional Chinese medicinal composition
CN102861241B (en) Traditional Chinese medicine qi-reinforcing and stasis-removing soup for treating acute myocardial infarction
CN103142849B (en) Chinese medicine preparation for treating acute vital myocarditis
CN102614474A (en) Traditional Chinese medicine for treating coronary heart disease and preparation method thereof
CN105796789A (en) Traditional Chinese medicine preparation for treating coronary heart disease
CN115770279A (en) Traditional Chinese medicine composition for treating chronic lower limb venous diseases and decoction and preparation thereof
CN101596302A (en) A kind of treatment treating coronary heart disease and angina pectoris and preparation method thereof
CN103479763B (en) Traditional Chinese medicine composition for treating borderline hypertension and preparation method thereof
CN103127351A (en) Traditional Chinese medicine for treating premature menstruation
CN103007192A (en) Chinese medicinal composition for treating thoracic obstruction
CN103599430B (en) A kind of Chinese medicine composition being used for the treatment of cardiac asthma
CN102579804B (en) Chinese medicine for treating stenocardia
CN102579633B (en) Traditional Chinese medicine composition for curing vital energy deficiency type postpartum lochiorrhea and preparation method thereof
CN105477452A (en) Traditional Chinese medicine for treating pulmonary emphysema
CN100459990C (en) Medicine for treating coronary heart disease and preparation method thereof
CN103127413B (en) Pharmaceutical preparation for treating coronary diseases
CN105055967A (en) Compound health care product having auxiliary blood sugar reducing function and preparation method
CN103736028A (en) Traditional Chinese medicine composition for treating oral lichen planus
CN103212041A (en) Chinese medicinal composition treating coronary heart disease
CN103263645B (en) Gastritis and gastric ulcer treatment drug
CN102228661B (en) Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis
CN102335203A (en) Miniature decoction
CN103191326B (en) Medicine preparation for treating coronary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140618

Termination date: 20140918

EXPY Termination of patent right or utility model